Theresa Comiskey Olsen
Directeur/Membre du Conseil chez GABATHER AB
Provenance du réseau au premier degré de Theresa Comiskey Olsen
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Aptahem AB
 Aptahem AB Pharmaceuticals: MajorHealth Technology Aptahem AB operates as a biotechnology company. The firm engages in developing drug candidates for the treatment and prevention of disease caused by blockages in blood vessels as the result of blood clots, such as deep vein thrombosis, stroke and heart failure. Its main business model is to clinically develop aptamer-based treatments for life-threatening acute conditions where coagulation and inflammation interact in the disease process. The company was founded byLuiza Jedlina, Bert Junno, Tina Persson and Johan Lindh in 2014 and is headquartered in Malmo, Sweden.
11
| Public Company | Pharmaceuticals: Major | 11 |
| Public Company | Pharmaceuticals: Major | 6 | |
| Public Company | Chemicals: Major Diversified | 3 | |
Melius Pharma AB
 Melius Pharma AB Pharmaceuticals: MajorHealth Technology Melius Pharma AB is a Swedish clinical stage pharmaceutical company that develops new treatments for chronic cough in idiopathic pulmonary fibrosis (IPF) patients. The company is based in Lund, Sweden and is privately owned, benefiting from the support of two of Sweden's most prominent professional life science investors who bring expertise to develop the company. IPF is a chronic, progressive lung inflammation characterized by fibrosis and disruption of normal lung architecture. Melius Pharma has developed ME-015, which stabilizes ion channels in the neuronal endings in the lungs that mediate cough. ME-015 is presumed to have an acute effect and is a solution for chronic cough, which is one of the major symptoms experienced by 80%% of IPF patients.
3
| Private Company | Pharmaceuticals: Major | 3 |
Farma Investment AS
 Farma Investment AS Real Estate Investment TrustsFinance Farma Investment AS invests in shares and real properties. The company was founded on June 23, 2011 and is headquartered in Oslo, Norway.
2
| Private Company | Real Estate Investment Trusts | 2 |
Nycomed ASA
1
| Extinct | Medical Specialties | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Theresa Comiskey Olsen via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| TAURUS ENERGY AB | Oil & Gas Production | Director/Board Member | |
| KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| NTG NORDIC TRANSPORT GROUP A/S | Trucking | Corporate Officer/Principal | |
| University of Oxford | College/University | Doctorate Degree Doctorate Degree | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of Cambridge | College/University | Doctorate Degree | |
| Stockholm School of Economics | College/University | Masters Business Admin | |
| University of Uppsala | College/University | Graduate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| University of Stockholm | College/University | Corporate Officer/Principal Graduate Degree | |
| ARCTICZYMES TECHNOLOGIES ASA | Medical Specialties | Director/Board Member | |
| Université de Bordeaux | College/University | Graduate Degree | |
| INVISIO AB | Telecommunications Equipment | Director/Board Member | |
| University of Lund | College/University | Doctorate Degree Director/Board Member Doctorate Degree Graduate Degree Undergraduate Degree | |
| University of Oslo | College/University | Doctorate Degree | |
| Vrije Universiteit Brussel | College/University | Doctorate Degree | |
| NAVAMEDIC ASA | Medical Distributors | Director/Board Member Director/Board Member | |
| Danmarks Farmaceutiske Universitet | College/University | Doctorate Degree | |
Axcentua Pharmaceuticals AB
 Axcentua Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Axcentua Pharmaceuticals AB develops anti-cancer drugs for pancreatic cancer patients. It generates investigational new drugs for diseases with unmet medical need in Sweden. The firm offers AXP107-11, multi-targeted chemosensitizer and a small-molecule anti-cancer compound for the treatment of various solid tumors, such as non-small cell lung cancers. The company was founded in 2007 by Anders Berkenstam, Stefan Rehnmark and Michael-Robin Witt and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Founder | |
| WNTRESEARCH AB | Pharmaceuticals: Other | Chief Executive Officer | |
| LIDDS AB | Pharmaceuticals: Major | Director/Board Member | |
| Swedish Pharmaceutical Society | Director/Board Member | ||
Forskarpatent i Syd AB
 Forskarpatent i Syd AB Miscellaneous Commercial ServicesCommercial Services Forskarpatent i Syd AB specialises in the commercialisation, through licensing or new venture spinouts, of patentable inventions emanating mainly from Swedish universities. It holds a portfolio of projects in the format of shares in spinouts, partnered (licensed) and still unpartnered assets. It is involves in projects in pharmaceutical, technology, and food categories. The firm is categorized under patent agency operations. The company was founded on January 18, 1996 and is headquartered in Lund, Sweden. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Balx 4 AB | Director/Board Member | ||
| Cardio Vax LLC | Director/Board Member | ||
| Jakten 7 AB | Director/Board Member | ||
PheroNet AB
 PheroNet AB Chemicals: AgriculturalProcess Industries PheroNet AB provides lures for insect monitoring. It offers insect pheromones for pest management, pheromone traps to detect harmful insect species in a crop, and synthetic pheromones for mating disruptions. Its products include adoxophyes orana, anarsia lineatella, bonagota cranaodes, cydia pomonella, cydia splendana, eupoecilia ambiguella, grapholita funebrana, grapholita lobarzewskii grapholita molesta, lobesia botrana, pammene rhediella, pandemis heparana, sparganothis pilleriana and spilonota ocellana. The company is headquartered in Alnarp, Sweden. | Chemicals: Agricultural | Chief Executive Officer | |
| DIAMYD MEDICAL AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| PAACS Invest AS | Chairman | ||
Galecto Biotech ApS
 Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Founder | |
| Ideonfonden AB | Director/Board Member Chief Executive Officer | ||
| Accequa AB | Chairman Founder | ||
| ARCEDE PHARMA AB | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| COMBIGENE AB | Pharmaceuticals: Major | Chairman | |
| CYXONE AB | Pharmaceuticals: Major | Founder Director/Board Member Chief Executive Officer | |
| EXACT THERAPEUTICS | Biotechnology | Director/Board Member | |
Fortuna Fix, Inc.
 Fortuna Fix, Inc. BiotechnologyHealth Technology Fortuna Fix, Inc. operates as a clinical-stage regenerative medicine firm. It develops a patented direct cell reprogramming technology platform (drNPC) and a proprietary bio-scaffolding technology (RMx), for the treatment of neurodegenerative diseases and neurotrauma. The company is headquartered in Laval, Canada. | Biotechnology | Founder | |
Pharmasum Therapeutics AS
 Pharmasum Therapeutics AS BiotechnologyHealth Technology Pharmasum Therapeutics AS operates as a pharmaceutical company. The firm focuses on the discovery and development of novel human medicines for the treatment of brain diseases, especially neurological diseases. The company was founded by Anders Fugelli and John Sigurd Svendsen is headquartered in Kvaloysletta, Norway. | Biotechnology | Director/Board Member | |
Sinfonia Biotherapeutics AB
 Sinfonia Biotherapeutics AB BiotechnologyHealth Technology Sinfonia Biotherapeutics AB is a clinical stage company based in Huddinge, Sweden. The Swedish company develops biologics for the treatment of neuropathic pain. | Biotechnology | Director of Finance/CFO | |
| ECTIN RESEARCH AB | Biotechnology | Director of Finance/CFO | |
| Lead Discovery Malaysia Sdn. Bhd. | Chief Executive Officer | ||
| Galecto Biotech AB | Founder Founder | ||
| Accequa GmbH | Director/Board Member Director/Board Member | ||
| Noviga Research AB | Founder | ||
Hemispherian AS
 Hemispherian AS Miscellaneous Commercial ServicesCommercial Services Hemispherian AS is a Norwegian company that focuses on epigenetic cancer therapeutics. The company is based in Oslo, Norway. The company's research and state-of-the-art technologies aim to transform cancer care and improve patient outcomes. The CEO of the company is Zeno Albisser. | Miscellaneous Commercial Services | Director/Board Member | |
| Gabather Finans AB | Director/Board Member | ||
| Aptahem Finans AB | Founder | ||
| Serstech Förvaltning AB | Director/Board Member Founder | ||
| SENSIDOSE AB | Electronic Equipment/Instruments | Director of Finance/CFO Director/Board Member | |
| BIOEXTRAX AB | Biotechnology | Director of Finance/CFO |
Statistiques
Internationale
| Suède | 32 |
| Norvège | 9 |
| Danemark | 4 |
| Royaume-Uni | 3 |
| France | 2 |
Sectorielle
| Health Technology | 17 |
| Consumer Services | 11 |
| Commercial Services | 5 |
| Electronic Technology | 3 |
| Energy Minerals | 2 |
Opérationnelle
| Director/Board Member | 100 |
| Founder | 33 |
| Chairman | 24 |
| Corporate Officer/Principal | 23 |
| Chief Executive Officer | 21 |
Relations les plus connectées
- Bourse
- Insiders
- Theresa Comiskey Olsen
- Connexions Sociétés
